Displaying 10 results for

Public health leaders are positioned to prevent illness from the "tripledemic” of COVID-19, Influenza, and RSV with approved vaccines and preventative antibody treatments.

Several states and territories, as well as many local governments, are going beyond recommendations and requiring individuals to wear face coverings when they are in public settings and spaces (i.e. grocery stores, retail stores, ...

This report highlights six public health approaches for addressing the rising incidence of substance use disorder and neonatal abstinence syndrome and draws out the critical role that state health leaders play in each.

As part of ASTHO’s annual Legislative Prospectus series, we are taking time this week to focus on efforts to end the HIV epidemic. Public health officials across all levels of government have been working to end the HIV epidemic, exploring ...

In-depth analysis on state health policy surrounding HIV. This is part of ASTHO's annual legislative prospectus series.

Continuing ASTHO’s Legislative Prospectus series—which highlights the top 10 public health policy issues for 2022—this post focuses on mental and behavioral health, as well as supporting the public health workforce.

The COVID-19 pandemic has had a particularly negative impact on the mental health of adolescent girls. Fortunately, state legislators have been addressing school-based mental health through legislation enacted since the beginning of the ...

Dental care and the oral health workforce have also been tremendously impacted by the COVID-19 pandemic. In the midst of stay at home orders, nationwide closures, and related employment loss, people have largely put their oral health on ...

February is Heart Month, a time to not only celebrate our love for others but also the organ that pumps us full of life - yet heart disease continues to be the leading cause of death in the U.S. This post is an overview of state ...

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: tobacco, HIV, mental health, PFAS, and opioids.